Celgene Reports Second Quarter 2016 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Celgene (CELG) Tops Q2 EPS by 6c; Boosts FY16 Outlook
July 28, 2016 7:33 AM EDTCelgene (NASDAQ: CELG) reported Q2 EPS of $1.44, $0.06 better than the analyst estimate of $1.38. Revenue for the quarter came in at $2.74 billion versus the consensus estimate of $2.7 billion.
REVLIMID® sales for the second quarter increased 18 percent year-over-year to $1,701 million and were driven by new... More
